122 related articles for article (PubMed ID: 6844922)
1. Cytotoxicity of a perfluorocarbon blood substitute to macrophages in vitro.
Bucala R; Kawakami M; Cerami A
Science; 1983 May; 220(4600):965-7. PubMed ID: 6844922
[TBL] [Abstract][Full Text] [Related]
2. Physiological effects of perfluorocarbon blood substitutes.
Lowe KC; Bollands AD
Med Lab Sci; 1985 Oct; 42(4):367-75. PubMed ID: 3908874
[No Abstract] [Full Text] [Related]
3. Oxygen therapeutics: perfluorocarbons and blood substitute safety.
Cohn CS; Cushing MM
Crit Care Clin; 2009 Apr; 25(2):399-414, Table of Contents. PubMed ID: 19341916
[TBL] [Abstract][Full Text] [Related]
4. Blood substitutes and oxygen therapeutics: an overview and current status.
Jahr JS; Nesargi SB; Lewis K; Johnson C
Am J Ther; 2002; 9(5):437-43. PubMed ID: 12237737
[TBL] [Abstract][Full Text] [Related]
5. [Effects of a fluorocarbon blood substitute on macrophage function and host defense in mice].
Zhang SN; Liu CF; Dong JW; Ding XC
Zhongguo Yao Li Xue Bao; 1986 Jan; 7(1):59-62. PubMed ID: 2945387
[No Abstract] [Full Text] [Related]
6. Doping with artificial oxygen carriers: an update.
Schumacher YO; Ashenden M
Sports Med; 2004; 34(3):141-50. PubMed ID: 14987124
[TBL] [Abstract][Full Text] [Related]
7. Perfluorocarbons in the twenty-first century: clinical applications as transfusion alternatives.
Spence RK
Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):367-80. PubMed ID: 7493058
[TBL] [Abstract][Full Text] [Related]
8. [Artificial oxygen carriers--perfluorocarbons].
Grünert A
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():57-62. PubMed ID: 7841781
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes.
Flaim SF
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1043-54. PubMed ID: 7849908
[TBL] [Abstract][Full Text] [Related]
10. Artificial Oxygen Carriers.
Malchesky PS
Artif Organs; 2017 Apr; 41(4):311. PubMed ID: 28397404
[No Abstract] [Full Text] [Related]
11. [Long term effects of intravenous infusion of fluorocarbon blood substitute in dogs].
Ding XC; Wang BS; Tang QN; Wang GF; Qin YQ; Liu YL
Zhongguo Yao Li Xue Bao; 1985 Dec; 6(4):270-3. PubMed ID: 2945371
[No Abstract] [Full Text] [Related]
12. Myocardial oxygen tension during fatal right heart failure following perfluorocarbon and radiographic contrast agent interaction.
Matschke K; Franke RP; Mrowietz C; Gerk U; Klosterhalfen B; Knaut M; Jung F
Clin Hemorheol Microcirc; 2005; 33(1):57-62. PubMed ID: 16037633
[No Abstract] [Full Text] [Related]
13. [Blood doping and cardiovascular consequences].
Gauthier J
Presse Med; 2002 Dec; 31(40):1904-8. PubMed ID: 12579085
[TBL] [Abstract][Full Text] [Related]
14. [The toxicity of surface-active substances for emulsifying perfluorocarbon compounds as components of blood substitute preparations].
Draffehn J; Reichelt H
Pharmazie; 1991 Apr; 46(4):271-2. PubMed ID: 1886917
[TBL] [Abstract][Full Text] [Related]
15. [Intravenous perfluorocarbons. Artificial oxygen carriers and their medical applications].
Frietsch T; Lenz C; Waschke KF
Dtsch Med Wochenschr; 2000 Apr; 125(15):465-72. PubMed ID: 10800445
[No Abstract] [Full Text] [Related]
16. Inflammation induced by perfluorocarbon liquid: intra- and postoperative use.
Figueroa MS; Casas DR
Biomed Res Int; 2014; 2014():907816. PubMed ID: 24783224
[TBL] [Abstract][Full Text] [Related]
17. [Hemorheologic studies on intravenous infusion of perfluorocarbon blood substitute in monkeys (author's transl)].
Ding XC; Jiang HX; Cao WJ; Wang GF; Chen F
Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):38-41. PubMed ID: 6211902
[No Abstract] [Full Text] [Related]
18. [Microcirculatory indices in the experimental therapy of acute blood loss using a blood substitute--an oxygen carrier based on perfluorodecalin].
Matvienko VP; Gusenova FM; Afonin NI; Aprosin IuD; Sidliarov DP
Gematol Transfuziol; 1983 Apr; 28(4):38-41. PubMed ID: 6852511
[No Abstract] [Full Text] [Related]
19. [Changes in lactate dehydrogenase activity and lactic and pyruvic acid concentration in the blood and tissues of animals following intravenous administration of perfluorotributylamine emulsions].
Afonin NI; Doronina NN; Smelova OS; Ivanova NL; Putiatina TK
Vopr Med Khim; 1980; 26(2):185-7. PubMed ID: 7456348
[TBL] [Abstract][Full Text] [Related]
20. Perfluorocarbons: future clinical possibilities.
Clark MC; Weiman DS; Pate JW; Gir S
J Invest Surg; 1997; 10(6):357-65. PubMed ID: 9654392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
